BI Asset Management Fondsmaeglerselskab’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
22,217
-29,381
-57% -$13.6M 0.09% 174
2026
Q1
$24.8M Buy
51,598
+36,731
+247% +$18.8M 0.26% 68
2025
Q4
$8.35M Sell
14,867
-577
-4% -$328K 0.07% 186
2025
Q3
$7.94M Buy
15,444
+6,692
+76% +$2.92M 0.07% 199
2025
Q2
$2.75M Buy
8,752
+884
+11% +$265K 0.03% 318
2025
Q1
$2.4M Sell
7,868
-8,025
-50% -$2.7M 0.03% 312
2024
Q4
$5.28M Sell
15,893
-2,269
-12% -$770K 0.06% 225
2024
Q3
$6.06M Buy
18,162
+6,341
+54% +$2.41M 0.11% 161
2024
Q2
$4.87M Buy
11,821
+175
+2% +$69.3K 0.08% 195
2024
Q1
$4.71M Sell
11,646
-2,403
-17% -$845K 0.09% 176
2023
Q4
$4.31M Sell
14,049
-1,236
-8% -$334K 0.09% 181
2023
Q3
$3.7M Buy
+15,285
New +$3.91M 0.09% 187

Other funds holding MEDP

BI Asset Management Fondsmaeglerselskab's MEDP Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab reduced its Medpace (MEDP) stake by 57% in Q2 2026, selling an estimated $13.6M and leaving 22,217 shares worth $11.8M. The position accounts for 0.09% of the portfolio, ranked #174.

BI Asset Management Fondsmaeglerselskab first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $24.8M in Q1 2026. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 22,217 shares of Medpace worth $11.8M as of Q2 2026.
  • BI Asset Management Fondsmaeglerselskab sold 29,381 Medpace shares in Q2 2026, an estimated $13.6M.
  • Medpace made up 0.09% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #174 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Medpace position peaked at $24.8M in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.